title: A uterine cavity-myoma communication after uterine artery embolization: two case reports.
abstract: OBJECTIVE
  To report two cases of uterine cavity-myoma fistula as a medical complication after uterine artery embolization.
  
  
  METHODS
  Case report.
  
  
  METHODS
  Women's Medical Center/Viscomi Institute, Sao Paulo, Brazil.
  
  
  METHODS
  Two patients presenting with symptomatic myomatous uterus: a 40-year-old woman with increased abdominal volume and hypermenorrhea, and a 42-year-old woman with pelvic pain and infertility.
  
  
  METHODS
  Uterine artery embolization, hysteroscopic follow-up, and laparoscopic myomectomy.
  
  
  METHODS
  Hysteroscopic follow-up after uterine artery embolization.
  
  
  RESULTS
  The patients underwent uterine artery embolization. In the months that followed, a subsequent surgical hysteroscopic follow-up was performed to eliminate the necrotic material of the degenerated myomas. The two patients presented the same outcome 1 year after the uterine artery embolization had been performed: a communication between the uterine cavity and a degenerated myoma. Laparoscopic correction of the uterine wall defect was performed afterward.
  
  
  CONCLUSIONS
  Because embolization is a growing option for the treatment of leiomyoma, it is important that potential complications be reported, especially if the patients want to become pregnant. The natural history of the fistula and its consequences are unknown, and physicians should be aware of these complications. Hysteroscopic follow-up was important in the diagnosis of the two cases.
authors.affiliation: Conception-Centro de Reprodução Humana, Caxias do Sul, Rio Grande do Sul, Brazil. karolyn@conception-rs.com.br
authors.forename: Karolyn Sassi
authors.initials: KS
authors.lastname: Ogliari
authors.forename: Soraya Vecci
authors.initials: SV
authors.lastname: Mohallem
authors.forename: Paulo
authors.initials: P
authors.lastname: Barrozo
authors.forename: Francesco
authors.initials: F
authors.lastname: Viscomi
mesh_terms: D000328:Adult; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000628:therapy*; D014594:Uterine Neoplasms / Q000628:therapy*; D014599:Uterus / Q000098:blood supply